Bakx Therapeutics specializes in oncology and is dedicated to the process of programmed cell death. Our focus lies in developing specific treatments for cancer by leveraging unique understandings of the structurally flexible protein catalysts within the mitochondrial apoptosis pathway, in combination with computer-based drug design and simulations. Our approach is built on a comprehensive and recurring system founded on expertise, experimentation, and modeling.